WSJ: Allergan said today that the FDA has approved its drug Latisse for “hypotrichosis of the eyelashes.†The company, which also sells Botox, helpfully explains that this is “another name for having inadequate or not enough eyelashes.†It’s a prescription drug that’s applied daily.

COMMENTS
Please let us know if you're having issues with commenting.